ADMA Biologics Inc (NASDAQ:ADMA)
| 3.55 Delayed Data As of 3:59pm ET |  +0.055 / +1.58%Today’s Change | 2.24 Today|||52-Week Range 4.65 | -8.63% Year-to-Date |
Latest ADMA News | Press Releases
| Adma Biologics (ADMA) Gains As Market Dips: What You Should Know Sep 21 / Zacks.com - Paid Partner Content | Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? Sep 13 / Zacks.com - Paid Partner Content |
| Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know Sep 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.49 |
| Today’s open | 3.51 |
| Day’s range | 3.51 - 3.60 |
| Volume | 43,392 |
| Average volume (3 months) | 2,079,522 |
| Market cap | $789.4M |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +35.11% |
| Earnings growth (this year) | +75.00% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +90.36% |
| P/E ratio | NM |
| Price/Sales | 4.98 |
| Price/Book | 5.12 |
Competitors
| ---- | ||
| SAVACassava Sciences Inc | -0.75 | -4.21% |
| BCYCBicycle Therapeutics... | -0.25 | -1.24% |
| IBRXImmunitybio Inc | -0.14 | -8.70% |
Data as of 4:00pm ET, 09/26/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $154.1M |
| Annual profit (last year) | -$65.9M |
| Net profit margin | -42.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ramsey, New Jersey |
Forecasts
